< 110 > INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY < 120 > Vaccine Composition for Viral Hemorrhagic Septicemia Using PLGA < 130 > PN 190061 < 160 > 24 < 170 > KoPatentIn 3 . 0 < 210 > 1 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > VHSV N Forward Primer < 400 > 1 atctggaggc aaagtgcaag 20 < 210 > 2 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > VHSV N Reverse Primer < 400 > 2 ccatgaggtt gtcgttgttg 20 < 210 > 3 < 211 > 19 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > Beta - actin Forward Primer < 400 > 3 cctcttccag ccttcattc 19 < 210 > 4 < 211 > 19 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > Beta - actin Reverse Primer < 400 > 4 tggttcctcc agatagcac 19 < 210 > 5 < 211 > 19 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IgM Forward Primer < 400 > 5 gcctccttct tctgctctg 19 < 210 > 6 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IgM Reverse Primer < 400 > 6 cctcagtgga tgttgtgatt 20 < 210 > 7 < 211 > 23 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IgT Forward Primer < 400 > 7 taattgttca gtaactcatg ccg 23 < 210 > 8 < 211 > 23 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IgT Reverse Primer < 400 > 8 gattgaagtg ttcctatgcg tct 23 < 210 > 9 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > pIgR Forward Primer < 400 > 9 aaggaggagg actctgggtg 20 < 210 > 10 < 211 > 19 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > pIgR Reverse Primer < 400 > 10 tggtgatggg tctggatgg 19 < 210 > 11 < 211 > 21 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > MHC I Forward Primer < 400 > 11 tctccctcct ctccagtcag c 21 < 210 > 12 < 211 > 23 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > MHC I Reverse Primer < 400 > 12 gctcatctgg aaggtcccgt cat 23 < 210 > 13 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > MHC II Forward Primer < 400 > 13 gtcgtcaggc ttcactctgt 20 < 210 > 14 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > MHC II Reverse Primer < 400 > 14 tctctttgcc agctcacttt 20 < 210 > 15 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IFN - gamma Forward Primer < 400 > 15 ctacaagcgg cgatatgatg 20 < 210 > 16 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > IFN - gamma Reverse Primer < 400 > 16 ggaggttctg gatggttttg 20 < 210 > 17 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > Mx Forward Primer < 400 > 17 tcactggatt tcccaacctc 20 < 210 > 18 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > Mx Reverse Primer < 400 > 18 tgtcactcaa actgctgctg 20 < 210 > 19 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TLR 7 Forward Primer < 400 > 19 cctgggaaat ctggaagaac 20 < 210 > 20 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > TLR 7 Reverse Primer < 400 > 20 tttgagggag gagaaactgc 20 < 210 > 21 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > C 3 Forward Primer < 400 > 21 ctgcgcacat tcctgagtta 20 < 210 > 22 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > C 3 Reverse Primer < 400 > 22 tactgctgga ccatctgctg 20 < 210 > 23 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > Caspase 3 Forward Primer < 400 > 23 acatcatgac acgggtgaac 20 < 210 > 24 < 211 > 20 < 212 > DNA < 213 > Artificial Sequence < 220 > < 223 > Caspase 3 Reverse Primer < 400 > 24 tccttcgtca gcattgacac 20